Varaico: Literature-Extracted Genetic Variants

Gene:TYR
Variant:p.C89R
Back to variants list

TYR

NM_000372.5:p.C89R

Associated Papers

Germline predisposition in multiple myeloma.

Martins Rodrigues F et al.

Iscience, 2025

39845416 (PubMed )
Supplement: mmc3.xlsx › ST2D.Vars_in_all_genes_MMRF

The ubiquitin-proteasome system in melanin metabolism.

Shi J et al.

Journal of Cosmetic Dermatology, 2022

Genetic Variability in Slovenian Cohort of Patients with Oculocutaneous Albinism.

Hovnik T et al.

Acta Chimica Slovenica, 2021

High-depth African genomes inform human migration and health.

Choudhury A et al.

Nature, 2020

33116287 (PubMed )
Supplement: 41586_2020_2859_MOESM3_ESM.xlsx › Supp_T19

Identification and Computational Analysis of Novel TYR and SLC45A2 Gene Mutations in Pakistani Families With Identical Non-syndromic Oculocutaneous Albinism.

Bibi N et al.

Frontiers in Genetics, 2020

32849781 (PubMed )
Supplement: Data_Sheet_2.docx

Ufd1 phosphorylation at serine 229 negatively regulates endoplasmic reticulum-associated degradation by inhibiting the interaction of Ufd1 with VCP.

Nguyen QT et al.

The Biochemical Journal, 2019

IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation.

Bayraktar O et al.

Plos One, 2016

Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1).

Ghodsinejad Kalahroudi V et al.

Plos One, 2014

A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.

Erzurumlu Y et al.

The International Journal of Biochemistry & Cell Biology, 2013

Mutational analysis of TYR gene and its structural consequences in OCA1A.

K B et al.

Gene, 2013

Genome-wide analysis to predict protein sequence variations that change phosphorylation sites or their corresponding kinases.

Ryu GM et al.

Nucleic Acids Research, 2009

19139070 (PubMed )
Supplement: gkn1008_nar-01723-s-2008-File009.xls › TypeII_

[New nonsense mutation (p.E250X) in the tyrosinase gene of a patient with oculocutaneous albinism type 1A].

Aquaron R et al.

Annales De Dermatologie Et De Venereologie, 2009

OCA1 in different ethnic groups of india is primarily due to founder mutations in the tyrosinase gene.

Chaki M et al.

Annals of Human Genetics, 2006

A novel mutation (delAACT) in the tyrosinase gene in a Cameroonian black with type 1A oculocutaneous albinism.

Badens C et al.

Journal of Dermatological Science, 2006

Tyrosinase maturation and oligomerization in the endoplasmic reticulum require a melanocyte-specific factor.

Francis E et al.

The Journal of Biological Chemistry, 2003

The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation.

Oetting WS

Pigment Cell Research, 2000

Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.

Halaban R et al.

Proceedings of the National Academy of Sciences of the United States of America, 2000

Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism.

Oetting WS et al.

Human Mutation, 1999

Analysis of tyrosinase mutations associated with tyrosinase-related oculocutaneous albinism (OCA1).

Oetting WS et al.

Pigment Cell Research, 1994

Molecular genetics of oculocutaneous albinism.

Spritz RA

Human Molecular Genetics, 1994

Molecular genetics of oculocutaneous albinism.

Spritz RA

Seminars in Dermatology, 1993

Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.

Oetting WS et al.

Human Mutation, 1993

Structural Details of Ufd1 Binding to p97 and Their Functional Implications in ER-Associated Degradation.

Le LT et al.

Plos One, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."